The QualityStocks Daily Wednesday, October 17th, 2018

Today's Top 3 StockMarketWatch

MarketClub Analysis (YECO) +569.69%

NetworkNewsWire (VMHG) +81.05%

Kiplinger Today (SHLD) +57.50%

The QualityStocks Daily Stock List

Impala Platinum Holdings Limited (IMPUY)

Zacks, YCharts, OTC Markets, Equity Clock, MarketWatch, GuruFocus, Marketbeat, Investopedia, and The Street reported on Impala Platinum Holdings Limited (IMPUY), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Impala Platinum Holdings Limited is a top producer of platinum and associated platinum group metals (PGMs). The Company is structured around five mining operations and Implats Refining Services, which is a toll refining business. Its operations are located on the Bushveld Complex in South Africa and the Great Dyke in Zimbabwe. The Company is Implats Platinum Limited’s 96 percent-owned main operational unit. Impala Platinum Holdings is based in Johannesburg, South Africa.

The Company operates through Mining Operations, Refining Services, Chrome Processing, and Other segments. Impala Platinum Holdings produces platinum, palladium, rhodium, as well as nickel.

Impala Platinum has operations on the western limb of the world-renowned Bushveld Complex close to Rustenburg, South Africa. This operation consists of a 13 shaft mining complex and concentrating and smelting plants. The base and precious metal refineries are in Springs, east of Johannesburg.

Impala Platinum Holdings announced at the beginning of March 2018 that it delivered an improved performance at most operations for the half year ended December 31, 2017. It reported a Gross Profit of R733 million for the period, in comparison to a Gross Loss of R139 million for the prior comparable period.

Impala’s improved operating performance resulted primarily from efficiencies at Impala Rustenburg, a strong operational turnaround at Marula, and a sustained performance from Zimplats. This resulted in an improved headline Loss per Share of 21 cents. This is a 70.4 percent improvement over the previous period.

Recently, Implats’ Rustenburg operations, Impala Platinum, in partnership with the North West Department of Education and Sports Development and the Impala Bafokeng Trust (IBT) officially opened three schools at a celebratory event in Rustenburg.

At the official opening event, Mr. Mark Munroe, Chief Executive of Impala Platinum, said, “Given the challenging social context of our country, we are firmly committed to investing in sustainable development initiatives in the communities that are home to our employees and their families. Our investment in housing and educational projects demonstrates our commitment to developing viable communities that can live close to work but also have access to high-quality facilities such as schools and health centers.”

Implats has informed of developments concerning the Government of Zimbabwe’s intention to compulsorily acquire land measuring 27,948 hectares within its subsidiary Zimplats’ special mining lease area. Implats advised that Zimplats has agreed to release to the Government land measuring 23,903 hectares within Zimplats’ mining lease area in support of the Government’s efforts to enable participation by other investors in the platinum mining industry in Zimbabwe. Following this release of ground, Zimplats now holds two separate and non-contiguous pieces of land measuring in total 24,632 hectares.

Impala Platinum Holdings Limited (IMPUY), closed Wednesday's trading session at $1.82, up 1.10%, on 23,410 volume with 24 trades. The average volume for the last 3 months is 54,493 and the stock's 52-week low/high is $1.10/$3.22.


CIB Marine Bancshares, Inc. (CIBH)

Stock Traders Chat, Amigo Bulls, Investor Hangout, CapitalCube, Stockhouse, InvestorsHub, OTC Markets, MarketWatch, 4-Traders, Morningstar, Marketwired, Investopedia, Zacks, TradingView, GuruFocus, Wallet Investor, Money Hub, Wallmine, Penny Stock Hub, YCharts, and Silicon Investor reported previously on CIB Marine Bancshares, Inc. (CIBH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CIB Marine Bancshares, Inc. operates as the bank holding company for CIBM Bank. The Bank provides banking and related services for small and middle-market business customers. OTCQB-listed, CIB Marine Bancshares is based in Waukesha, Wisconsin. The Bank also has offices in Central and Northeastern Illinois, Milwaukee, and Indianapolis markets.

Incorporated in 1985, CIB Marine Bancshares operates through Banking and Mortgage Banking segments. It accepts demand, savings, as well as time deposits.

CIBM Bank operates as Marine Bank in its Indiana and Wisconsin markets, Central Illinois Bank in its central Illinois market, and Avenue Bank in its Chicagoland market. Located in Naperville, Illinois, the Avenue Mortgage division of the Bank serves all CIBM Bank markets.

CIBM Bank provides traditional banking services. These include a broad array of loan products. These include commercial loans, commercial real estate loans, commercial and residential construction loans, one-to-four family residential real estate loans, consumer loans, and commercial and standby letters of credit.

In addition, services the Bank provides include acceptance of demand, savings and time deposits; commercial paper and repurchase agreements, and other banking services.

This past April, CIB Marine Bancshares announced its results of operations and financial condition for Q1 of 2018. Pre-tax Net Income for the quarter ending March 31, 2018, was $1.0 million versus $0.9 million for March 31, 2017.

Pre-tax Basic Net Income per Share was $0.05 and $0.03 on a diluted basis for the quarter ending March 31, 2018, versus $0.05 and $0.02, respectively, for the same period ending March 31, 2017.

Mr. J. Brian Chaffin, CIB Marine Bancshares’ President and Chief Executive Officer, said in April, “We were able to improve pre-tax earnings in the first quarter of 2018 compared to the same period last year on improved net interest income and higher mortgage revenues. Our asset quality, reflected through our non-performing assets and non-accrual loan ratios, continued to improve and achieved new cyclical lows.”

CIB Marine Bancshares, Inc. (CIBH), closed Wednesday's trading session at $1.55, up 2.65%, on 100 volume with 1 trade. The average volume for the last 3 months is 5,332 and the stock's 52-week low/high is $1.35/$1.99.


MYnd Analytics, Inc. (MYND)

Simply Wall St, 4-Traders, Barchart, OTC Markets, The Street, Business Insider, Bzweekly, Stock Twits, Zacks, Equity Clock, Capital Cube, BioSpace, MarketWatch, GuruFocus, and Marketbeat reported on MYnd Analytics, Inc. (MYND), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

MYnd Analytics, Inc. is a market leader in decreasing costs and improving the delivery of mental health services through the combination of telemedicine and data analytics/artificial (augmented) intelligence. A predictive medicine company, MYnd brings objective physical findings to psychiatric treatment to reduce trial and error treatment in mental health. The Company provides an innovative set of reference data and analytic tools for clinicians and researchers in psychiatry. MYnd Analytics is based in Mission Viejo, California.

The Company has its Psychiatric EEG Evaluation Registry, or PEER Online®. The aim of PEER Online is to provide objective, personalized data to assist physicians in the selection of appropriate medications. PEER Online is a cloud-based platform. It is a registry and reporting platform. It enables medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained by way of a standard electroencephalogram (EEG).

PEER combines a "crowdsourced" secure physician outcome registry with electroencephalogram (EEG), an accepted, well-normed test of brain function. EEG is a totally painless, non-invasive test. It records one’s brain’s electrical activity.

MYnd Analytics has its MYnd Analytics Center. This Center provides a convenient, relaxing, and welcoming environment for one to receive their EEG and PEER Report™. The EEG is performed on-site at the MYnd Analytics Center. It generally takes under one hour. The EEG and PEER Report are available by appointment only. Physicians who use PEER reduce trial and error prescribing.

MYnd Analytics announced in February of this year that it received its first notice of patent allowance in Canada on its neuromodulation platform for predicting patients likely to respond to Transcranial Magnetic Stimulation (TMS). The patent is entitled “Method for Assessing the Susceptibility of a Human Individual Suffering from a Psychiatric or Neurological Disorder to Neuromodulation Treatment.” It provides patent protection through 2029. 

MYnd Analytics continues to integrate its recently acquired Arcadian Telepsychiatry Services LLC business into its legacy business. Recently, MYnd Analytics announced that its wholly-owned subsidiary, Arcadian Telepsychiatry Services launched a new program to offer, via its network of Providers, youths in rural, suburban and urban markets with school-based access to telepsychiatry, teletherapy and other mental health services.

Telepsychiatry involves the use of video conferencing equipment to conduct real time mental health consultations between a clinician and a patient. The design of this program is to benefit children and teenagers throughout the nation, particularly those with limited access to mental health services.

MYnd Analytics, Inc. (MYND), closed Wednesday's trading session at $1.54, down 2.54%, on 65,968 volume with 179 trades. The average volume for the last 3 months is 458,372 and the stock's 52-week low/high is $1.15/$4.29.


Nickel Creek Platinum Corp. (NCPCF)

InvestorsHub, InvestorX, The Frugal Forager, Northern Miner, Stockhouse, Metals News, Business Insider, OTC Markets, Investors Hangout, Wallmine, and Portfolio Sharing reported earlier on Nickel Creek Platinum Corp. (NCPCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nickel Creek Platinum Corp. is a mining exploration and development company headquartered in Toronto, Ontario. Its focus is on advancing its 100 percent-owned Nickel Shäw Project with the aim of creating Canada's next world-class nickel sulphide mine. The Company previously went by the name Wellgreen Platinum Ltd. It changed its corporate name to Nickel Creek Platinum Corp. in January of this year. Nickel Creek Platinum lists on the OTC Markets Group’s OTCQX.

The 100 percent-owned Nickel Shäw project is positioned in the southwest of Canada’s Yukon Territory, around 317 km northwest of the capital, Whitehorse. The Project has excellent access to infrastructure, located three hours west of Whitehorse via the paved Alaska Highway, which further provides year-round access to deep-sea shipping ports in southern Alaska.

Nickel Shäw is host to more than 2 billion pounds of nickel, 1 billion pounds of copper, 6 million ounces of platinum group metals (PGM's) and 120 million pounds of cobalt in the Measured and Indicated categories. The Nickel Shäw Property lies within the Kluane First Nation core area as defined by their treaty with Canada and the Yukon Government.

Nickel Creek Platinum reported this past July the final results of its Phase II Metallurgical Program on the Nickel Shäw Project. The Phase II Metallurgical Program succeeded in its primary objective of separating bulk CuNi concentrate into separate saleable nickel and copper concentrates. This represents the most in-depth and comprehensive metallurgical undertaking completed so far at the Project.

Last month, Nickel Creek Platinum announced an update on the status of its Nickel Shäw Project. Following the conclusion of the Company’s Phase II Metallurgical Program, it embarked on more work toward completing a Preliminary Economic Assessment (PEA).  During the course of the Phase II Metallurgical Program, it reported that it identified a strong correlation between nickel recovery and total sulphide content.

Particularly, it was determined that the presence of sulphides (sulphur in pyrrhotite) was an important marker of nickel recovery. This means that the areas of higher sulphur yielded higher recoveries, and areas of lower sulphur yielded lower recoveries, irrespective of nickel head grade, which remains relatively consistent throughout the deposit.

Nickel Creek Platinum Corp. (NCPCF), closed Wednesday's trading session at $0.07176, up 1.07%, on 41,290 volume with 16 trades. The average volume for the last 3 months is 144,126 and the stock's 52-week low/high is $0.0685/$0.296.


Nemaura Medical, Inc. (NMRD)

Market Exclusive, OTC Markets, and 4-Traders reported on Nemaura Medical, Inc. (NMRD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nemaura Medical, Inc. is a medical technology business listed on the NasdaqCM. The Company is developing the wireless sugarBEAT® disposable adhesive skin-patch as a non-invasive, needle-free, pain-free, and affordable continuous glucose monitoring (CGM) system for adjunctive use by diabetics. Nemaura Medical is based in Loughborough, England.

The Company’s patient-friendly technology has the potential to transform health monitoring through providing real-time, tailored feedback on glucose, lactate, and other vital body performance metrics. Its patented BEAT™ technology (passing a mild, non-perceptible electric current across the skin) draws a small number of selected molecules, such as glucose, into a patch placed on the skin.

These molecules are drawn out of the interstitial fluid. The patch (by way of a sensor) measures the amount of that molecule present, converting it into a meaningful concentration value for clinical diagnosis or preliminary guidance for self-treatment.

The BEAT™ technology will permit remote continuous monitoring of chronic diseases and health conditions. It is to replace traditional invasive methods of diagnosis and healthcare observation procedures.

The sugarBEAT® App can be pre-downloaded on a user’s smart device. There is an optional sugarBEAT® handheld reader (applicable where a user chooses not to use their own smart device).

sugarBEAT® provides accurate glucose measurement. sugarBEAT® comprises a reusable transmitter containing a daily-disposable adhesive skin-patch.

Nemaura Medical announced at the end of January 2018 positive summary data for its sugarBEAT® European clinical trial program. The summary results were taken from a 25 patient cohort of the earlier reported European three-stage 75 patient Clinical study, consisting of 80 percent Type 1 and 20 percent Type 2 Diabetics.

Results indicate an overall MARD (Mean Absolute Relative Difference) of 13.76 percent over an extensive dynamic glucose concentration range. Up to 70 percent of the data from the study paired between sugarBEAT® and the venous blood glucose concentration achieved an average MARD of 10.28 percent, denoting even greater accuracy. No serious or major device related adverse events were noted. A MARD of 10 percent is considered to be sufficient for making therapeutic decisions.

Recently, Nemaura Medical announced that it entered into a definitive joint Collaboration Agreement with Dallas Burston Ethitronix (DBE) to commercialize sugarBEAT® in the European Economic Area (EEA). Nemaura Medical earlier signed a licensing agreement with DBE for the commercialization of sugarBEAT® in the United Kingdom (UK) and Ireland.

DBE and Nemaura Medical are in discussions with a number of large international organizations active in the Diabetes space with established infrastructure and market presence, concerning appointing one or more sub-distributors to cover European territories. DBE and Nemaura will share equally in all income and expenditure under the terms of the agreement.

Nemaura Medical, Inc. (NMRD), closed Wednesday's trading session at $2.10, up 6.06%, on 37,121 volume with 65 trades. The average volume for the last 3 months is 158,450 and the stock's 52-week low/high is $1.93/$6.80.


Emergent Capital, Inc. (EMGC)

OTC Markets, MarketWatch, and 4-Traders reported on Emergent Capital, Inc. (EMGC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Emergent Capital, Inc. is a specialty finance company. It invests in life settlements and is a global leader in the life settlements industry. The Company has decades of experience creating value via the secondary and tertiary markets for life insurance policies. Emergent Capital established in 2006 as Imperial Holdings, LLC. Since 2011 it has been publicly traded.

Emergent Capital has its corporate headquarters in Boca Raton, Florida. In 2015, shareholders voted to change the Company’s name to Emergent Capital, Inc.

Regarding Life settlements; they are an alternative asset class, which can provide high uncorrelated returns. For investor consideration, life settlements have limited correlation to the stock market or the larger economic market. They can serve as a hedge against the volatility of more market-dependent investments. Furthermore, life settlements represent a compelling and diversified investment opportunity to include longevity risk in a portfolio.

Emergent Capital has access to an extensive and proven network of life settlement brokers and third-party providers from whom it sources attractive and value-added policies. As of December 31, 2017, the Company owned a portfolio of 608 life insurance policies.

Fundamentally, Emergent Capital buys individual policies and portfolios of life insurance policies. It manages these assets based on comprehensive actuarial and market data.

In addition, an Emergent Capital subsidiary can act as a life settlement provider in more than 30 states where it is able to pursue numerous opportunities within the life settlement space.

The Company’s aim is to produce a consistent flow of investment opportunities encompassing all aspects of the life settlements marketplace. These range from lending to outright purchases of portfolios, to tertiary trades, as well as individual secondary market purchases.

Emergent Capital announced this past January that, on January 22, 2018, it entered into a stock purchase agreement with SB Holdings, Inc., a California corporation, and Sherman, Clay & Co. an Indiana corporation and wholly-owned Subsidiary of SB Holdings Inc.

Emergent Capital agreed to purchase all of the issued and outstanding capital stock of Sherman Clay for an initial purchase price of 18,000,000 shares of the Company's common stock par value $0.01 per share, subject to adjustment under certain circumstances.

On May 29, 2018, Emergent Capital announced that shares of its common stock were approved for trading on the OTCQX® Best Market. Trading on the OTCQX commenced on Tuesday, May 29th.

Pat Curry, Emergent Capital Chief Executive Officer (CEO), said, "Since completing the corporate recapitalization of Emergent in July 2017 and joining the company as CEO in October 2017, we have focused on enhancing transparency and implementing best practice corporate governance. Upgrading from the OTCQB to the OTCQX is the next logical step in our strategy as we work to unlock and maximize shareholder value."

Emergent Capital, Inc. (EMGC), closed Wednesday's trading session at $0.235, up 4.44%, on 21,900 volume with 10 trades. The average volume for the last 3 months is 122,164 and the stock's 52-week low/high is $0.2101/$0.225.


Fortem Resources, Inc. (FTMR)

Wolf Street, Stockwatch, OTC Markets, YCharts, InvestingOnline, Wallet Investor, Stockopedia, Marketbeat, Stockhouse, 4-Traders, Simply Wall St, InvestorsHub, Barchart, and Real Investment Advice reported on Fortem Resources, Inc. (FTMR), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Fortem Resources, Inc. is an oil and gas production, development, and exploration company. It has a diversified natural resource portfolio of mainly oil and gas assets and one gold asset. Fortem Resources has offices in Calgary, Alberta, and North Orem, Utah. Established in 2004, the Company formerly went by the name Strongbow Resources, Inc. It changed its name to Fortem Resources, Inc. in March 2017.

The Company’s properties are located in Western Canada, North America, and internatioanlly via five wholly-owned subsidiaries. These subsidiaries are Rolling Rock Resources, Black Dragon Energy, Colony Energy, Big Lake Energy, and City of Gold.

Fortem Resources announced in 2017 that it indirectly acquired by way of Rolling Rock Resources, LLC, a wholly-owned subsidiary, an undivided 75 percent interest in more oil and gas leases in the Mancos formation covering 2,313.09 acres. With an agreement entered into with Rockies Standard Oil Company, LLC, who holds the remaining 25 percent interest, the parties agreed to enter into a joint operating agreement covering the new leases. The leases are outside the AMI (Area of Mutual Interest) of its original joint venture (JV) lease holdings.

Regarding Fortem Resources’ Rolling Rock Resources subsidiary, Rolling Rock has the right to acquire a 50 percent working interest (WI) in and to certain leases, hydrocarbons, wells, agreements, equipment, surface rights agreements and assignable permits totaling around 101,888 acres (160 sections) at an 80 percent Net Revenue Interest (NRI) located in the Mancos formation in the Southern Uinta Basin, Utah.

This month, Fortem Resources announced that it entered into an asset purchase agreement with a major Canadian oil and gas company to purchase a 100 percent WI in three Oil Leases encompassing a total of 20,719 hectares (51,200 acres) of heavy oil in north central Alberta. The rights to the Oil Leases, cover heavy oil of 12-16 API situated near the top of the Viking formation to the base of the Woodbend Group. The acquisition of the Oil Leases complements Fortem's existing land holdings of 12,800 acres directly adjacent to and to the south of the Oil Leases.

Fortem Resources, Inc. (FTMR), closed Wednesday's trading session at $2.30, down 8.00%, on 19,927 volume with 28 trades. The average volume for the last 3 months is 3,844 and the stock's 52-week low/high is $1.98/$3.95.


Intrusion, Inc. (INTZ)

Zacks, Investor Place, Wallstreet Online, Morningstar, Market Screener, InvestorsHub, InvestingOnline, Marketbeat, 4-Traders, Wallet Investor, Barchart, The Street, Stockopedia, Capital Cube, OTC Markets, and MarketWatch reported on Intrusion, Inc. (INTZ), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Intrusion, Inc. is an international provider of entity identification, high speed data mining, cybercrime, and advanced persistent threat detection products. The Company’s product families include TraceCop™ for identity discovery and disclosure, and Savant™ for network data mining and advanced persistent threat detection. OTCQB-listed, Intrusion is headquartered in Richardson, Texas.

The Company’s products help protect critical information assets. These products do so through quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private, and regulated information for government and enterprise networks.

Intrusion’s TraceCop is a set of Internet monitoring and tracking products. They provide exceptional capabilities for the identification of malicious and illegal activities based on historical and current Internet usage data. TraceCop helps analysts and investigators significantly reduce the time and complexity for discovering identities, ownership, and contact information for computer devices on the Internet.

At the heart of TraceCop is a premier data collection process. The process continuously collects, processes and stores wide-ranging amounts of historical Internet usage and traffic data into the TraceCop Databases.

Intrusion’s Savant is a transparent network data capture and analysis solution. Savant brings science into corporate decision making. It provides real-time access and insight into an enterprise’s own indisputable and quantifiable network data for more effective, unbiased decision making. Savant is a purpose-built appliance. It performs an innovative, real-time, transparent data capture and analysis of all content across a company’s network. This includes the “who, what, when and where” of the data from any application.

Intrusion also has its Secure Taps™. It offers a collection of secure network taps. These enable easy, quick, and strong deployment of any of the Company’s network security appliances. Using a Secure Tap is a first-rate method for deploying network appliances.

This past August, Intrusion announced financial results for the three and six months ended June 30, 2018. Net Income was $474,000 in Q2 2018, versus a Net Loss of $438,000 in Q2 2017 and Net Income of $346,000 in Q1 2018. Revenue for Q2 2018 was $2.4 million versus $1.5 million in Q2 2017 and $2.3 million for Q1 2018.

Intrusion, Inc. (INTZ), closed Wednesday's trading session at $2.58, up 1.57%, on 9,430 volume with 17 trades. The average volume for the last 3 months is 9,850 and the stock's 52-week low/high is $0.261/$2.59.


CloudCommerce, Inc. (CLWD)

Epic Stock Picks, Wolf of Penny Stocks, MoneyTV, InvestorsHub, MarketWatch, and Investor News Source reported previously on CloudCommerce, Inc. (CLWD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

CloudCommerce, Inc. is a provider of cloud commerce services to foremost brands. The Company is a global provider of cloud-driven e-commerce and mobile commerce solutions. Furthermore, CloudCommerce strategically acquires profitable cloud commerce solutions providers with strong management teams. The Company’s aim is to be a full-service provider of cloud commerce solutions for medium, large, and international enterprises. OTCQB-listed, CloudCommerce is headquartered in Santa Barbara, California.

The Company’s goal is to capitalize on the growth in technology industry subsets: Security Technology, Cloud Computing, Business Analytics, Storage, and Wireless, through acquiring strong companies in a roll-up strategy. CloudCommerce’s services include the development of highly customized and sophisticated online stores; real-time integration to other business systems; digital marketing and data analytics; complete and secure site management; and integration to physical stores.

CloudCommerce’s digital marketing division will provide a variety of services. These services include Content Marketing, Marketing Automation, Social Media Strategy/Marketing, Search Marketing, Account-Based Marketing, Sales Enablement, Data Analytics, and Brand Strategy/Brand Experiences.

CloudCommerce’s plan is to expand into these areas of focus by way of direct sales efforts to existing clients, prospective clients and joint partnerships, and via the strategic acquisition of digital marketing services firms.

CloudCommerce earlier acquired Indaba Group of Denver, Colorado. Indaba Group is a strategic e-Commerce agency. Indaba specializes in enterprise software development, e-Commerce platform development, creative services, and also customer experience management. Indaba concentrates on the Magento platform.

CloudCommerce acquired 100 percent of WebTegrity, Inc. in 2017. WebTegrity is a provider of enterprise digital marketing services. WebTegrity serves clients including Generations Federal Credit Union, University Health System, UTSA, Petco Foundation, and Animal Defense League.

CloudCommerce also acquired 100 percent of Parscale Creative, Inc. last year Parscale Creative comprises certain assets spun out of Giles-Parscale, Inc., a San Antonio, Texas-based company owned by Brad Parscale and Jill Giles. Parscale Creative was renamed Parscale Digital, Inc. Parscale is a provider of enterprise digital marketing services.

Recently, CloudCommerce announced it launched Data Propria, Inc. Data Propria of San Antonio is a data and behavioral science company. Its focus is on aligning companies with the right audience, with the right message, and at the right time to produce a measurable behavioral change and boost revenue.

Data Propria's services will be provided as stand-alone offerings or in combination with more comprehensive marketing services provided by other CloudCommerce divisions.

CloudCommerce, Inc. (CLWD), closed Wednesday's trading session at $0.0125, up 13.64%, on 40,000 volume with 1 trade. The average volume for the last 3 months is 59,654 and the stock's 52-week low/high is $0.008/$0.057.


BioCardia, Inc. (BCDA)

Penny Stock Hub, Investing Note, Penny Stock Tweets, Stockwatch, Stockopedia, Simply Wall St, Journal Transcript, Wallmine, TradingView, Insider Financial, 4-Traders, Marketbeat, and MarketWatch reported earlier on BioCardia, Inc. (BCDA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

BioCardia, Inc. is a leader in the development of complete solutions for cardiovascular regenerative therapies. Its biotherapeutic product candidates in clinical development are CardiAMP® (autologous minimally processed bone marrow cells [a patient’s own cells]) and CardiALLO® (allogenic culture expanded mesenchymal stem cells derived from bone marrow [donor-derived]) cell therapies. A clinical-stage regenerative medicine company, BioCardia has its corporate office in San Carlos, California.

The Company’s two therapeutic programs are enabled by its Helix™ transendocardial delivery systems and Morph® vascular access products, which are partnered to enable other promising biotherapeutic programs. Additionally, the Helix transendocardial delivery system is being used by several clinical partners in biotherapeutic clinical trials.

The Helix transendocardial delivery system is the foremost percutaneous catheter delivery system for cardiovascular regenerative medicine. Helix enables the local delivery of cell and gene-based therapies to treat heart failure, myocardial infarction, ischemia, and cardiac conduction disorders. BioCardia’s CardiALLO uses younger universal donor mesenchymal stem cells. The Company states that CardiALLO may be suitable for patients who are not optimal candidates for the CardiAMP therapy.

CardiAMP harnesses the potential of autologous minimally processed bone marrow cells, utilizing a companion diagnostic to identify patients most likely to benefit from the therapy. The design of the investigational CardiAMP cell therapy system is to deliver a high dose of a patient’s own bone marrow cells directly to the area of cardiac dysfunction to stimulate the body’s natural healing mechanism after a heart attack.

In September, BioCardia announced the issuance of two United States patents. U.S. Patent No. 10,035,982 relates to methods of preparing culture-expanded cells for the treatment of heart failure. This patent has broad claims on an approach for expanding mesenchymal stem cells in media derived from the blood of the same donor who has provided the source cells for culture expansion.

The second issued patent, U.S. Patent No. 10,071,226, describes a system for delivery of biotherapeutic agents to the heart. The patent claims a catheter system that may be used to attain heart access from the radial artery in a patient's wrist and subsequently advanced into a chamber of the heart to directly deliver biologic therapies.

Recently, BioCardia announced that positive data from two studies of its investigational CardiAMP stem cell therapy were presented on September 24, 2018 at the Transcatheter Cardiovascular Therapeutics (TCT) conference. Nine month results from the 10-patient roll-in cohort of the CardiAMP Heart Failure Trial (a Phase III pivotal trial) showed clinically meaningful improvements in symptoms, quality of life and exercise capacity, as measured by New York Heart Association class, Minnesota Living with Heart Failure Questionnaire and Six Minute Walk Distance, respectively.

BioCardia, Inc. (BCDA), closed Wednesday's trading session at $2.72, down 0.73%, on 500 volume with 1 trade. The average volume for the last 3 months is 9,256 and the stock's 52-week low/high is $1.124/$5.52.


GulfSlope Energy, Inc. (GSPE)

TipRanks, Emerging Growth, MarketWatch, Infront Analytics, Stockhouse, OTC Markets, Simply Wall St, Barchart, InvestorsHub, Morningstar, Equity Clock, and Financial Times reported on GulfSlope Energy, Inc. (GSPE), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

GulfSlope Energy, Inc. is an independent oil and natural gas company centering on exploring offshore U.S. Gulf of Mexico. The Company uses 2.2 million acres of 3D seismic data to identify high quality exploration prospects. Its team has a track record of discovering and developing multi-billion-dollar projects around the world, with more than 300 years of combined experience in the oil and gas exploration industry. GulfSlope Energy is headquartered in Houston, Texas.

The Company’s target is the Shelf Miocene (2.2 MM Acres - 440 Blocks). GulfSlope’s present focus is on pre-drill operations. It has a hybrid operating model with a preference to operate. The Miocene Subsalt Play – La Shelf has large resource potential; is low to moderate risk; has moderate drilling and development costs; has shortened times to initial production, and enhanced economics.

Concerning its Phase 1 Drilling Program, GulfSlope Energy has high-graded five prospects with mean unrisked resource potential of 623 MMboe. It is looking to capitalize on strategic advantages provided by exploration work to identify undervalued producing assets. The Company has greater than 2 billion boe of net conventional recoverable resources. It has 23 lease blocks with 19 drilling prospects ranging from 30-280 MMboe. The average size of the prospects is 120 MMboe.

GulfSlope Energy and Texas South Energy, Inc. (TXSO) have entered into a strategic partnership with Delek Group Ltd., an international independent oil and gas company based in Israel. The Companies and Delek have mutually agreed to pursue oil and natural gas opportunities in the Gulf of Mexico.

In late August 2018, GulfSlope Energy announced drilling results for the GulfSlope Energy OCS-G-35589 #1 well on Vermilion Block 378 (VR 378) known as the Canoe Shallow Prospect. Based on Logging-While-Drilling (LWD) and Isotube analysis of hydrocarbon samples, oil sands were encountered in the northwest center of the block.

The well was drilled to a total of 5,765 feet measured depth (5,700 feet true vertical depth). No problems were encountered while drilling. A complete integration of the well information and seismic data will be performed for further evaluation of the shallow potential of the wellbore and the block, and to define commerciality of these oil plays.

GulfSlope Energy recently announced that on September 13, 2018, it started drilling of its initial subsalt exploration well in the Gulf of Mexico on the Tau Prospect located on Ship Shoal Area, South Addition Blocks 336/351.  The Tau Prospect is being drilled with the high-spec Rowan Ralph Coffman jack-up rig that recently completed drilling operations on GulfSlope’s Canoe Prospect.

Mr. John N. Seitz, Chief Executive Officer of GulfSlope Energy, said, “This is the first well to be drilled in our exciting portfolio of high potential subsalt prospects.  Advancements in both imaging and drilling technologies are what enable this play today.  Reverse Time Migration (RTM) depth imaging and critical noise suppression technologies allowed our geoscientists to establish an improved subsurface image below salt.”

GulfSlope Energy, Inc. (GSPE), closed Wednesday's trading session at $0.048, down 2.04%, on 427,405 volume with 24 trades. The average volume for the last 3 months is 1,316,667 and the stock's 52-week low/high is $0.0346/$0.20.


First Choice Healthcare Solutions, Inc. (FCHS)

First Penny Picks,, 007 Stock Chat, PennyStockSpy, Greenbackers, StocksImpossible, TheMicrocapNews, and OTCBB Journal reported on First Choice Healthcare Solutions, Inc. (FCHS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

First Choice Healthcare Solutions, Inc. (FCHS) engages in owning and operating multi-specialty (non-physician-owned) medical centers of excellence across the southeastern U.S. The Company is one of the nation's only non-physician-owned, publicly traded healthcare services enterprises focused on the delivery of total musculoskeletal solutions with an emphasis on Orthopaedic and Spine care. OTCQB-listed, FCHS is headquartered in Melbourne, Florida.

The Company’s commitment is to deliver clinically superior, patient-centric care. At present, its flagship integrated platform administers more than 100,000 patient visits each year. The platform comprises First Choice Medical Group, The B.A.C.K. Center, and Crane Creek Surgery Center.

FCHS medical centers of excellence concentrate on treating patients in different specialties. This includes Orthopaedics, Spine Surgery, Neurology, Interventional Pain Management, and related diagnostic and ancillary services.

First Choice Medical Group (Melbourne, Florida) is the Company’s flagship multi-specialty medical center of excellence. First Choice Medical Group specializes in the delivery of musculoskeletal medicine and rehabilitative care with numerous quality-focused goals centered on enriching its patients’ care experience.

FCHS has expanded its portfolio of Medical Centers of Excellence in the Florida Space Coast area with its Brevard Orthopaedic Spine & Pain Clinic, Inc. (d/b/a The B.A.C.K. Center). The B.A.C.K. Center is a foremost, advanced orthopaedic spine and pain practice in Brevard County, Florida.

FCHS’s Crane Creek Surgery Center is an AAAHC accredited facility. Its commitment is to deliver premier, ambulatory surgical care in a convenient, comfortable outpatient environment. The 18,000-plus sq. ft. facility is in Melbourne, Florida within the Crane Creek Medical Center building. In addition, this building is home to The B.A.C.K. Center.

FCHS announced this past February that one of its wholly-owned subsidiaries, CCSC Holdings, Inc. acquired an additional 25 percent ownership interest in Crane Creek Surgery Center. This brings its total ownership interest to 65 percent. CCSC Holdings has also assumed management responsibility of Crane Creek and ended the previous agreement with NueHealth.

FCHS recently announced the closing of its strategic partnership with Steward Health Care System. Steward is the largest private hospital operator in the U.S. FCHS closed its strategic partnership with Steward to expand its business model into Steward’s national footprint. FCHS received an investment of $7.5 million from Steward in exchange for 5 million shares of FCHS stock.

Mr. Chris Romandetti, FCHS President and Chief Executive Officer, stated, “2017 was a transformative year for First Choice, having achieved several significant milestones in our business that have successfully laid the foundation for future growth. Most notable is our strategic partnership with Steward Health Care (Steward) which provides us with a large geographic opportunity to rollout our unique delivery platform to Steward’s nationwide hospital network.”

For Q1 2018, FCHS had Total Revenue of $8.8 million. This represents an increase of 14 percent versus $7.7 million for the same period in 2017. Net Income Attributable to First Choice was $279,338 for Q1 2018, versus Net Income of $202,519 for the same period in 2017. This represents an increase of 38 percent.

First Choice Healthcare Solutions, Inc. (FCHS), closed Wednesday's trading session at $1.0135, up 0.35%, on 13,625 volume with 14 trades. The average volume for the last 3 months is 13,625 and the stock's 52-week low/high is $0.91/$1.46.


Nutritional High International, Inc. (SPLIF)

SmallCapVoice, Daily Marijuana Observer, CFN Media Group, Barchart, Insider Financial, 4-Traders, Promotion Stock Secrets, Wallet Investor, News, Marketwired, and The Street reported on Nutritional High International, Inc. (SPLIF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Nutritional High International, Inc. concentrates on developing, manufacturing, and distributing products and nationally recognized brands in the hemp and marijuana-infused products industries. These include edibles and oil extracts for nutritional, medical, as well as adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law. Nutritional High International is headquartered in Toronto, Ontario.

Concerning its Marijuana-Infused Products segment, Nutritional High focuses on developing, acquiring, and designing Marijuana-Infused Products (MIPs) and Marijuana Concentrate products and brands. With this segment, it is establishing operations in Colorado and Illinois. It is working to expand into more U.S. States in support of its strategy to establish some of the first nationally-recognized brands for MIPs.

Regarding its Hemp-Infused Products segment, the Company launched the first product in its Active Hemp category under the brand of “Nutritional Traditions”. For this segment, first distribution will center on California and Colorado via cannabis-related retail stores: medical marijuana dispensaries, vape lounges and headshops; and Food Supplement retail stores.

Nutritional High International entered into an agreement to acquire the technology and Intellectual Property (IP) rights to an innovative product to be referred to as the “Dab Stick”. The Dab Stick is a dispenser for viscous liquid substances. It can carry approximately 1⁄2 gram of cannabis oil extract designed with the retail consumer and adult use user in mind.

Nutritional High International has signed a definitive agreement for the acquisition of Pasa Verde. This is a commercial scale cannabis oil extraction and edible facility in Sacramento, California. Pasa Verde produces a number of extract products on a contract manufacturing basis for leading brands. It will produce Nutritional High's FLÏ™ branded oil and edible products.

At the beginning of October, Nutritional High International announced that it entered into formal agreements to acquire 75 percent of Nevada-based Green Therapeutics LLC, along with a put and call option to buy the remaining 25 percent interest. The Company had earlier entered into a Letter Of Intent (LOI) to undertake the Acquisition. Entering into the formal Membership Interest Purchase Agreement (MIPA) permits Nutritional High to proceed to submit filings to the relevant Nevada State and municipal regulatory bodies for approval for the ownership change.

Today, NeutriSci International, Inc., the innovator and pioneer behind neuenergy®, and Nutritional High International provided a further update on their earlier announced partnership. The first production run for the newly developed chewable, sublingual cannabis product (NU Tablets) for distribution and sale in California, is on course and underway at Nutritional High's FLI NorCal facility in Sacramento, California.

Delivery of the initial purchase orders are set for next month. Initial distribution by Nutritional High's distributor, Calyx, will begin to roughly 450-plus dispensaries throughout California. Unveiling of the finished packaging and branding will be released before the initial shipment to dispensaries.

In addition, today, Nutritional High International and Aura Health, Inc. announced the development of a framework to bring Nutritional High’s extraction and edibles technology and products to Israeli and European markets. The Company will work with Aura Health to outfit Aura with the knowledge and expertise to extract cannabis oil using Nutritional High’s cryo ethanol process and other extraction methods. Aura Health will develop health and wellness products that subsequently may be licensed to Nutritional High for distribution in the United States.

Nutritional High International, Inc. (SPLIF), closed Wednesday's trading session at $0.236, down 6.46%, on 588,593 volume with 107 trades. The average volume for the last 3 months is 205,551 and the stock's 52-week low/high is $0.088/$0.942.


Regen BioPharma, Inc. (RGBP)

Small Cap Solutions, InvestorTrendz, Insider Financial, TopPennyStockMovers, YCharts, ProTrader, Emerging Growth, SmallCapVoice, Wall Street Mover, TheMicrocapNews, and The OTC Reporter reported earlier on Regen BioPharma, Inc. (RGBP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Regen BioPharma, Inc. is a biotechnology company listed on the OTC Markets’ OTCQB. The Company works to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. Its aim is to quickly advance these technologies through pre-clinical and Phase I/II clinical trials. Checkpoint Immunology, Inc. is a wholly-owned subsidiary of the Company. Regen BioPharma has its head office in La Mesa, California.

At present, Regen BioPharma is focusing on checkpoint inhibitor and gene silencing therapies for treating cancer. Furthermore, it is focusing on developing stem cell treatments for aplastic anemia. Fundamentally, the Company is working to increase the quality of life through therapies involving small molecules, stem cell treatments, and the body's own immune system. It is currently developing products treating blood disorders employing small molecules and gene silencing (DiffronC) and treating cancer with immunotherapy (dCellVax).

Regen BioPharma is also modulating vital molecular processes in cancer stem cells by way of its patented molecular targeting approaches (BORIS). In addition, it is repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate).

Regen BioPharma is centering on small molecules to activate and inhibit its main target of interest, NR2F6. The Company is continuing to develop the NR2F6 program in-house before entering into any potential partnerships. It has granted CheckPoint Immunology an exclusive international license to develop and commercialize Regen's NR2F6 technology for human therapeutic use. The objective of the license grant is the separation of Regen BioPharma’s small molecule technology from its other Intellectual Property (IP) to facilitate any future transactions involving small molecule therapies focused on the NR2F6 checkpoint.

In September, Regen BioPharma reported that its researchers identified a series of small molecule drugs, which inhibit NR2F6 as well as activate human immune cells ex-vivo. Evidence provided by studies suggest that NR2F6 represses the body's immune response against tumors. Therefore, inhibiting NR2F6 may lead to enhanced immune response against cancerous tumor cells.

Harry Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen BioPharma, said, "Based on the known activities of NR2F6, we expect that inhibiting its activity will lead to increased T cell activation. We found that several of our NR2F6 antagonists can activate human immune cells, such as T cells, leading to increased IL-17a production in a concentration-dependent manner."

Earlier this month, Regen BioPharma reported that its researchers determined that its lead NR2F6 small molecule agonist, RG-NAH005, is now ready for testing in animal models of inflammatory bowel disease (IBD). Regen will pursue this testing as a joint venture (JV) with Zander Therapeutics, Inc. Zander Therapeutics has been granted an exclusive license by Regen to develop and commercialize the Company's NR2F6 IP for veterinary applications.

Regen BioPharma, Inc. (RGBP), closed Wednesday's trading session at $0.0115, up 21.05%, on 3,750,456 volume with 86 trades. The average volume for the last 3 months is 732,009 and the stock's 52-week low/high is $0.00575/$0.1277.


The QualityStocks Company Corner

Victory Marine Holdings Corp. (VMHG)

The QualityStocks Daily Newsletter would like to spotlight Victory Marine Holdings Corp. (VMHG).

Victory Marine Holdings Corp. (VMHG) is a world-class yacht sales, brokerage and consulting firm with a sprawling inventory of new and used boats, financing, insurance, documentation and recreational marine accessories. Located in Miami, Florida – the “yacht capital of the world” – Victory Marine has over 20 years of experience in an industry hailed as “an American pastime and economic engine” by the National Marine Manufacturers Association (“NMMA”).

According to the NMMA, marine sales reached $39 billion in 2017. To capture its share of this market, Victory Marine has established partnerships with several selective manufacturers and is pursuing opportunities for vertical growth. While the company’s near-term focus is on expansion of its inventory and sales team, its longer-term plans reflect the current state of the broader yacht industry.

Marine sales are at a 10-year high, and though yacht manufacturers are operating at full capacity, delivery of some products can take longer than 18 months. As a result, Victory Marine is taking steps to establish its own pipeline. Management is currently in negotiations with several yacht manufacturers to build the company its own unique, private-label design, which would enable Victory Marine to quickly deliver a superior product to its clients.

Demand for recreational boat trailers is also on the rise, with growth reported for nearly all powerboat segments. Florida continues to ride the top of that crest with sales of powerboats, trailers, and accessories up 10 percent in 2017 to $2.9 billion, followed by Texas ($1.7 billion) and Michigan ($982 million).

Victory Marine’s wholly owned Excalibur Trailers USA subsidiary is set to take advantage of this market, and is approved by the Society of Automotive Engineers (SAE International) to build custom marine aluminum trailers for recreational boats, as well as for commercial boat transport. Excalibur Trailers USA has filed the necessary paperwork to trademark its brand name and logo and is seeking a suitable manufacturing facility in South Florida for production of powerboat, sailboat, catamaran, powerboat and Jet Ski trailers.

Leading Victory Marine to capture its share of the market is company CEO Orlando Hernandez, whose experience in the marine industry includes negotiation, business planning, investor relations, operations management and sales. He is joined by veteran yacht broker Gary Beaver, who has more than 20 years of successful yacht sales and industry experience. Beaver brings to Victory Marine his portfolio of approximately 25 vessel listings, valued in excess of $10 million.

Victory Marine Holdings Corp. (VMHG), closed the day's trading session at $0.235, up 81.05%, on 41,394 volume with 33 trades. The average volume for the last 3 months is 42,249 and the stock's 52-week low/high is $0.084/$0.97.

Recent News


American Premium Water Corp. (HIPH)

The QualityStocks Daily Newsletter would like to spotlight American Premium Water Corp. (HIPH).

American Premium Water Corporation (OTC: HIPH) announces that it has created a prototype tetrahydrocannabinol (THC)-infused beverage utilizing the Company’s hydro-nano technology, and that it is engaged in discussions with Canadian distributors and U.S. dispensaries.  Upon official launch, American Premium expects to offer the first hydro-nano-infused THC beverage on the market. Also today, the company was highlighted in a report on SinglePoint Inc. (OTC:SING), which recently signed a distribution agreement with the manufactures of Lalpina CBD Water, American Premium Water Corporation.

American Premium Water Corp. (HIPH), headquartered in Playa Vista, California, is a diversified holding company, manufacturer, distributor and marketer of branded consumer products. HIPH, the acronym for “Hi-Power of Hydro,” maintains a portfolio of subsidiaries catering to the health-conscious consumer and luxury fashion brand connoisseur. The company’s two main pillars focus on the development of health and beauty biotech, dedicated to unlocking the power of hydrogen and nanotechnologies. Paired with cannabidiol or “CBD” in a unique beverage, the technology is proving to be a significant health and wellness option for astute consumers.

Among the company’s holdings are:

  • LALPINA Hydro beverages mix hydrogen with nanotechnology into consumer beverages that combine the best of health, nutrition and fitness to deliver short and long-term therapeutic health benefits. LALPINA Hydro utilizes atomic molecular hydrogen, or diatomic hydrogen, which converts antioxidants in the body to H2O to further enhance hydration, which helps increase endurance, reduce lactic acid and melt away fatigue. Over 500 peer-reviewed articles demonstrate hydrogen to have therapeutic potential in essentially every organ of the human body and in 150 different human disease models.
  • LALPINA Hydro CBD is a technically superior CBD-infused beverage. Using hydro and nanotechnology, LALPINA Hydro CBD encapsulates water molecules with cannabidiol molecules, making them infinitely more bioavailable and accelerating delivery to the body’s cells and tissues. Each bottle of LALPINA Hydro CBD contains 3 million nanograms of CBD free from the psychoactive compound THC (tetrahydrocannabinol). HIPH is the first to introduce a hydro-nano CBD-infused beverage on the market, which is a more effective delivery mechanism for administering CBD into the blood stream than traditional beverages or oils, with up to a 90 percent higher absorption rates.

The company recently signed a distribution agreement for its subsidiary, LALPINA Hydro CBD, to sell its beverages to two SinglePoint, Inc. (OTCQB: SING) e-commerce channels: and SING is a technology and investment company with a portfolio that includes mobile payments, blockchain solutions and ancillary cannabis services. HIPH will drop ship its product to the customers.

HIPH CEO Ryan Fishoff said the e-commerce arrangements “could bring in excess of a million of revenue over the life of the agreement.” The agreement serves as a pillar of the company’s e-commerce distribution strategy, driving awareness and impressions for the LALPINA brand.

In addition, HIPH seeks to market emerging fashion brands and leverage its relationship with classic retail partners while incorporating disruptive blockchain technologies to expand its retail footprint with the following:

  • Gents, a producer of luxury hats and other fine accessories and apparel, was acquired in September 2017. Gents is distributed across many luxury retail outlets including Saks Fifth Avenue, Bloomingdales, Nordstrom, and other high-end channels. The company added the Worthy streetwear brand to its portfolio in June 2018.
  • HIPH also acquired the license to operate the FashionCoinX exchange, a blockchain exchange focused on creating utility tokens for the fashion industry, and created THRD Coin, a multi-branded utility rewards token that is also the first token to be traded on the exchange. The company is leveraging its retail footprint and expertise in the fashion and apparel space with the burgeoning blockchain sector.

American Premium Water Corp. (HIPH), closed the day's trading session at $0.118, up 50.32%, on 77,026,871 volume with 4,077 trades. The average volume for the last 3 months is 13,960,310 and the stock's 52-week low/high is $0.0035/$0.132.

Recent News


SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTC:SING) is excited to announce a successful first week of sales of the newly listed product Lalpina CBD Water. SingleSeed has already received 25 orders for the 12 pack cases of water in the first week. The water has been a nice success so far and has drove sales of other products listed on SingleSeed as well. SingleSeed supplies multiple different hemp-based CBD products. The company is in a perfect position to continue adding relationships for additional distribution of products. Also today, the company was highlighted in a report on distribution partner American Premium Water Corporation’s (OTC: HIPH) announcement that it has created a prototype tetrahydrocannabinol (THC)-infused beverage utilizing the Company’s hydro-nano technology.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.03475, up 25.00%, on 12,225,921 volume with 504 trades. The average volume for the last 3 months is 4,104,401 and the stock's 52-week low/high is $0.0235/$0.133.

Recent News


Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Digitalization has changed our world, most tellingly in the ways we communicate, but also in a hundred other areas; yet it seems to have largely bypassed the energy sector, which, in many parts of the country, still serves up electricity the way it has been doing for over a century. However, in Texas at least, that is changing, as Zenergy Brands, Inc. (OTC: ZNGY) continues on its mission to enrich businesses and consumers through responsible energy use and management.

Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0004, even for the day, on 138,325,517 volume with 49 trades. The average volume for the last 3 months is 16,772,595 and the stock's 52-week low/high is $0.0003/$0.029.

Recent News


Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (OTCQB: SGMD), one of the largest publicly traded hydroponics supply companies, today announces the signing of a binding Letter of Intent ("LOI") to acquire Sky Unlimited, LLC, dba Athena United (, a California-based supplier of cannabis cultivation materials to wholesalers and large commercial cannabis cultivators. Also today, the company was highlighted in a report explaining how demand for cannabis continues to outpace projections as Canada will officially commenced its legalization of recreational marijuana. According to the Cannabis Business Plan, recreational cannabis could experience annual revenues north of $8 billion by 2020 in Canada. Additionally, the company was highlighted today by pioneer in digital financial market media, 24/7 Market News.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include:;; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.


CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.1447, up 23.13%, on 8,498,867 volume with 1,054 trades. The average volume for the last 3 months is 2,049,613 and the stock's 52-week low/high is $0.029/$0.43.

Recent News


The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

North American demand for legal marijuana is expected to jump dramatically as Canada will officially commenced its legalization of recreational marijuana today. According to the Cannabis Business Plan, recreational cannabis could experience annual revenues north of $8 billion by 2020 in Canada alone. This is forcing industry leaders to reinvest profits into the expansion of cultivation efforts as the consumer base grows and new markets emerge. And this is music the the ears of companies like The Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (OTCQX:TGODF), which just received its medical sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations for its Ancaster, Ontario facility.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $4.46, up 5.44%, on 1,365,433 volume with 3,300 trades. The average volume for the last 3 months is 1,038,038 and the stock's 52-week low/high is $2.784/$7.894.

Recent News


Sunniva, Inc. (CSE: SNN) (OTC: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF), a North American provider of cannabis products and services, is pleased to announce that the Company has signed a non-arms length binding letter of intent dated October 16, 2018 with the Oakland Vision Project (“Vision”) to acquire all the issued and outstanding equity interests of the companies that comprise Vision (the “LOI”). Additionally, the company was highlighted today by pioneer in digital financial market media, 24/7 Market News.

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $4.00, up 4.17%, on 233,484 volume with 427 trades. The average volume for the last 3 months is 81,717 and the stock's 52-week low/high is $3.61/$16.00.

Recent News


First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

Vertically integrated North American pure-play cobalt company First Cobalt’s (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) Iron Creek property looks to provide promising opportunity in the hunt for cobalt needed to power EVs and the new age of technology. To view the full article, visit: Also today, the company was highlighted in a report detailing how the United States — and the entire world — have become critically dependent on cobalt, which is essential for rechargeable lithium ion (Li-ion) batteries to retain and discharge electricity.

First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.22, up 4.76%, on 207,329 volume with 45 trades. The average volume for the last 3 months is 219,480 and the stock's 52-week low/high is $0.198/$1.3041.

Recent News


QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals Corp. (TSX-V: QMC) (FSE: 3LQ) (OTC PINK: QMCQF) (“QMC” or "the Company") is pleased to provide an update on the Company’s 100% owned Irgon Lithium Mine Project located within the prolific Cat Lake-Winnipeg River rare-element pegmatite field of S.E. Manitoba, which also hosts Cabot Corporation’s nearby Tantalum Mining Corporation of Canada (“TANCO”) rare-element pegmatite. Also today, NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, announced the publication of an editorial featuring QMC Quantum Minerals. To view the full publication, titled “Changes in the Lithium Market Drive Growth in Canadian Mining,” visit:

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.256726, up 3.02%, on 56,699 volume with 32 trades. The average volume for the last 3 months is 119,305 and the stock's 52-week low/high is $0.169/$1.46.

Recent News


BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company focused on immuno-oncology, recently announced the completion of several important milestones in 2018. These include obtaining topline safety and efficacy data in a clinical trial, achieving proof of concept and advancing the BriaCell clinical program.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.08134, even for the day. The average volume for the last 3 months is 15,693 and the stock's 52-week low/high is $0.068/$0.139.

Recent News


Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) has taken a significant step in adapting its payment processing technology to the specific challenges of the tourism and hospitality industry through its recently announced partnership with VIP Systems, an advanced technology integrator already working in the hospitality industry space (

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $3.91, off by 3.22%, on 76,044 volume with 343 trades. The average volume for the last 3 months is 100,743 and the stock's 52-week low/high is $3.47/$33.51.

Recent News


Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures, Inc. (NUGS) was featured today in a report from CannabisNewsWire explaining that, while the U.S. customs authorities may be unsure about how to respond once recreational marijuana becomes legal in Canada, social media giant Facebook has taken the step to stop preventing search results from showing in case a user is looking for cannabis pages, articles and organizations, among other kinds of related content.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $3.69, off by 2.89%, on 18,730 volume with 94 trades. The average volume for the last 3 months is 104,718 and the stock's 52-week low/high is $0.031/$7.13.

Recent News


Canopy Rivers Inc. (TSX.V: RIV)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV).

Canopy Rivers Inc. (TSX.V: RIV) was featured today in a report from CannabisNewsWire explaining that, while the U.S. customs authorities may be unsure about how to respond once recreational marijuana becomes legal in Canada, social media giant Facebook has taken the step to stop preventing search results from showing in case a user is looking for cannabis pages, articles and organizations, among other kinds of related content.

Canopy Rivers Inc. (TSX.V: RIV) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $5.35, off by 7.12%, on 1,229,281 volume with 2,114 trades. The average volume for the last 3 months is 291,387 and the stock's 52-week low/high is $3.188/$11.82.

Recent News


VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Harvest Medicine Inc. (“Harvest Medicine” or “HMED”), has completed the acquisition of Trauma Healing Centres (“THC”) from Organigram Holdings Inc..

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.97, off by 5.83%, on 621,040 volume with 541 trades. The average volume for the last 3 months is 591,050 and the stock's 52-week low/high is $0.73/$3.29.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.